Marcela Maus, MD, PhD

Secretary (2025-2028)


Marcela Maus, M.D., Ph.D., is the Paula O’Keefe Chair in Oncology and Director of Cellular Immunotherapy at Massachusetts General Hospital (MGH) Cancer Center, an Attending Physician in the Cell Therapy division of Oncology at MGH, and Professor of Medicine at Harvard Medical School. She is an Associate Member of the Broad Institute of Harvard and MIT.

Dr. Maus is internationally known for her work as a translational physician-scientist in the field of immunology, particularly as it relates to T-cell immunotherapies in the treatment of cancer. Her laboratory focuses on the biology of human T cell activation, costimulation, and cell-cell interactions, and on the application of human T cell therapies to human disease, including forward and reverse translation of engineered T cell therapies in early-phase clinical trials. She has authored over 200 papers and holds multiple NIH R01 grants and several Investigational New Drug Applications (IND’s).

Dr. Maus completed undergraduate studies at Massachusetts Institute of Technology (MIT) and holds graduate degrees (M.D., Ph.D.) from University of Pennsylvania. Dr. Maus trained in internal medicine at University of Pennsylvania and in hematology and medical oncology at Memorial Sloan Kettering Cancer Center. She also serves on several scientific and clinical advisory boards for the biotechnology industry as well as external academic medical centers.

2025

ASGCT Policy Summit

Sept. 25-26, 2025 | Washington, D.C.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.